| Literature DB >> 29988521 |
Ajay K Verma1, Da Xu2, Michelle Bruner2, Amanmeet Garg3, Nandu Goswami4, Andrew P Blaber1,2, Kouhyar Tavakolian1,2.
Abstract
Autonomic control of blood pressure is essential toward maintenance of cerebral perfusion during standing, failure of which could lead to fainting. Long-term exposure to microgravity deteriorates autonomic control of blood pressure. Consequently, astronauts experience orthostatic intolerance on their return to gravitational environment. Ground-based studies suggest sporadic training in artificial hypergravity can mitigate spaceflight deconditioning. In this regard, short-arm human centrifuge (SAHC), capable of creating artificial hypergravity of different g-loads, provides an auspicious training tool. Here, we compare autonomic control of blood pressure during centrifugation creating 1-g and 2-g at feet with standing in natural gravity. Continuous blood pressure was acquired simultaneously from 13 healthy participants during supine baseline, standing, supine recovery, centrifugation of 1-g, and 2-g, from which heart rate (RR) and systolic blood pressure (SBP) were derived. The autonomic blood pressure regulation was assessed via spectral analysis of RR and SBP, spontaneous baroreflex sensitivity, and non-linear heart rate and blood pressure causality (RR↔SBP). While majority of these blood pressure regulatory indices were significantly different (p < 0.05) during standing and 2-g centrifugation compared to baseline, no change (p > 0.05) was observed in the same indices during 2-g centrifugation compared to standing. The findings of the study highlight the capability of artificial gravity (2-g at feet) created via SAHC toward evoking blood pressure regulatory controls analogous to standing, therefore, a potential utility toward mitigating deleterious effects of microgravity on cardiovascular performance and minimizing post-flight orthostatic intolerance in astronauts.Entities:
Keywords: artificial gravity; astronauts; blood pressure regulation; cardiovascular deconditioning; long duration spaceflight; microgravity; orthostatic intolerance; short-arm human centrifuge
Year: 2018 PMID: 29988521 PMCID: PMC6026653 DOI: 10.3389/fphys.2018.00712
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Detailed demographic information of study participants.
| Participant # | Age | Height | Weight | Gender |
|---|---|---|---|---|
| 1 | 23 | 172 | 73 | Male |
| 2 | 31 | 165 | 55 | Female |
| 3 | 24 | 164 | 56 | Female |
| 4 | 25 | 169 | 62 | Female |
| 5 | 25 | 176 | 75 | Male |
| 6 | 35 | 175 | 76 | Male |
| 7 | 23 | 165 | 53 | Female |
| 8 | 29 | 175 | 79 | Male |
| 9 | 24 | 174 | 55 | Female |
| 10 | 35 | 189 | 84 | Male |
| 11 | 39 | 178 | 73 | Male |
| 12 | 37 | 166 | 72 | Male |
| 13 | 32 | 169 | 68 | Female |
Values (mean ± SD) of cardiovascular parameters during different experimental conditions.
| Parameters | Baseline | Stand | Recovery | 1-g | 2-g |
|---|---|---|---|---|---|
| R-R (ms) | 967 ± 177 | 754 ± 135† | 957 ± 155 | 879 ± 158 | 669 ± 115†‡ |
| SBP (mmHg) | 110 ± 15 | 122 ± 21 | 118 ± 13 | 119 ± 16 | 114 ± 21 |
| DBP (mmHg) | 58 ± 9 | 65 ± 17 | 62 ± 10 | 61 ± 12 | 61 ± 16 |
| MAP (mmHg) | 74 ± 11 | 80 ± 18 | 78 ± 12 | 76 ± 12 | 74 ± 17 |
Values (mean ± SD) of blood pressure regulatory indices in response to different experimental conditions.
| Blood pressure regulatory indices | Baseline | Stand | Recovery | 1-g | 2-g |
|---|---|---|---|---|---|
| SBPV LF (n.u.) | 0.72 ± 0.13 | 0.51 ± 0.16 | 0.68 ± 0.15 | 0.54 ± 0.23 | 0.42 ± 0.21† |
| SBPLF (n.u.) | 0.20 ± 0.13 | 0.33 ± 0.12† | 0.18 ± 0.08 | 0.31 ± 0.11 | 0.35 ± 0.17† |
| SBPHF (n.u.) | 0.08 ± 0.06 | 0.16 ± 0.13 | 0.13 ± 0.16 | 0.16 ± 0.18 | 0.22 ± 0.13 |
| SBPV LF (mmHg2) | 22.02 ± 11.58 | 21.60 ± 11.78 | 22.43 ± 20.63 | 16.07 ± 16.14 | 29.67 ± 32.84 |
| SBPLF (mmHg2) | 5.80 ± 3.95 | 14.36 ± 8.44† | 5.19 ± 4.05 | 6.91 ± 4.86 | 20.93 ± 13.02†‡ |
| SBPHF (mmHg2) | 1.89 ± 1.01 | 6.41 ± 6.49 | 1.94 ± 1.36 | 2.37 ± 1.97 | 11.41 ± 8.44†‡ |
| RRLF (n.u.) | 0.44 ± 0.20 | 0.65 ± 0.17† | 0.40 ± 0.22 | 0.56 ± 0.17 | 0.71 ± 0.11† |
| RRHF (n.u.) | 0.56 ± 0.20 | 0.35 ± 0.17† | 0.60 ± 0.22 | 0.44 ± 0.17 | 0.29 ± 0.11† |
| RRLF/HF | 1.11 ± 1.04 | 2.89 ± 2.53† | 0.99 ± 0.96 | 1.69 ± 1.33 | 3.08 ± 1.91† |
| RRLF (second2) | 1.45 ± 1.40 | 1.25 ± 1.31 | 1.25 ± 1.42 | 1.50 ± 2.06 | 1.23 ± 1.09 |
| RRHF (second2) | 2.53 ± 3.14 | 1.01 ± 1.89† | 3.78 ± 6.43 | 1.88 ± 3.53 | 0.51 ± 0.60† |
| BRSupslope (ms/mmHg) | 31.18 ± 20.19 | 10.40 ± 4.78† | 30.65 ± 20.91 | 20.10 ± 9.43 | 7.52 ± 3.38†‡ |
| BRSdownslope (ms/mmHg) | 29.31 ± 18.15 | 10.85 ± 6.39† | 27.51 ± 16.78 | 21.32 ± 10.16 | 6.80 ± 2.67†‡ |
| RR→SBP | 0.95 ± 0.03 | 0.93 ± 0.03 | 0.93 ± 0.03 | 0.92 ± 0.05 | 0.92 ± 0.04 |
| SBP→RR | 0.83 ± 0.09 | 0.91 ± 0.03* | 0.88 ± 0.07 | 0.91 ± 0.04* | 0.89 ± 0.05 |
Comparison of changes in blood pressure regulatory indices inflicted by different experimental conditions.
| Variables and conditions to compare | Baseline vs. stand | Baseline vs. recovery | Baseline vs. 1-g | Baseline vs. 2-g | Stand vs. 1-g | Stand vs. 2-g |
|---|---|---|---|---|---|---|
| SBPV LF (n.u.) | 0.07 | 0.99 | 0.17 | 0.001a | 0.99 | 0.79 |
| SBPLF (n.u.) | 0.04b | 0.99 | 0.09 | <0.001a | 0.99 | 0.79 |
| SBPLF (abs power) | 0.01a | 0.99 | 0.90 | <0.001a | 0.12 | 0.79 |
| SBPHF (abs power) | 0.09 | 0.99 | 0.98 | <0.001a | 0.27 | 0.41 |
| RRLF (n.u.) | 0.13 | 0.79 | 0.85 | 0.007a | 0.65 | 0.85 |
| RRHF (n.u.) | 0.12 | 0.79 | 0.85 | 0.007a | 0.65 | 0.85 |
| RRLF/HF | 0.12 | 0.79 | 0.85 | 0.007a | 0.65 | 0.85 |
| RRHF (abs power) | 0.02b | 0.99 | 0.12 | 0.001a | 0.97 | 0.90 |
| BRSupslope | 0.007a | 0.99 | 0.41 | <0.001a | 0.48 | 0.79 |
| BRSdownslope | 0.003a | 0.99 | 0.65 | <0.001a | 0.16 | 0.72 |
| SBP→RR | 0.007a | 0.21 | 0.04b | 0.16 | 0.98 | 0.79 |